Medical
Stay up-to-date on the latest medical cannabis research, news, and information with Business of Cannabis. Learn about new treatments, laws, and more.
Medical · page 22
- Press releases
Cannavigia to Expand US Operations as Medical Cannabis Rescheduling Remains a Focus
CANNAVIGIA (by Vigia AG), a global pioneer in cannabis compliance software and consulting, is expanding its presence in the U.S. market, building on recent regulatory developments related to the potential rescheduling of medical cannabis to Schedule III.
- CBD Market
Ananda Aiming to ‘Meet Regulators at Their Point of Need’ As it Secures More Major UK Clinical Cannabis Trials
UK-based biotech firm Ananda Developments has solidified its position as a driving force in clinical cannabis research in Europe, announcing the launch of two more major trials using its proprietary compounds.
- Medical
Luxembourg Moves to Roll Back Access to Medical Cannabis Flower
As reported by Cannabis Health Luxembourg is set to restrict access to high-THC cannabis flower on prescription from next year, as part of longer-term plans to phase out flower-based products altogether.
- Press releases
Medical Cannabis ‘Should Not be Home Office Issue’ Says CIC
Responsibility for all medical cannabis policy and regulation should sit with the Department of Health and Social Care (DHSC), according to the Cannabis Industry Council (CIC).
- Medical
New Era for Medical Cannabis in Denmark as Government Announces Plans for Permanent Legal Framework
Denmark’s six-year medical cannabis pilot scheme could soon be expanded into a fully legalised market, following a surprise announcement from the government last week.
- Opinion
From Specialists to GPs: Releaf on Expanding Access to Medical Cannabis Training in the UK
Business of Cannabis recently sat down with Releaf’s Chief Operating Officer, Graham Woodward, a trained psychiatric nurse and former clinical director and CQC Specialist Advisor, to discuss the impact of the lack of access to training how clinics such as Releaf are working to change it.
- Adult-Use
Cannabis Business Licenses Decline in 2024 Amid Regulatory Restructuring and Market Tightening
The number of active US cannabis business licenses – including those in regulated medical and recreational markets – continued to decline through the third quarter of 2024 as reductions in established markets outpaced growth in emerging ones.
- Medical
Germany’s Medical Cannabis Imports Grow 70% in Q3 as Market Explosion Continues
Germany’s Federal Institute for Drugs and Medical Devices (BfArM) has published the medical cannabis import figures for Q3, showing that the country’s medical cannabis market is still growing rapidly.
- Cultivation
Energy Entrepreneur’s £40m UK Cannabis Take – ‘I Can Help People And Make Money, Too’
Over the last five years experienced UK entrepreneur James Short has invested around £40m creating one of the country’s first medical cannabis production facilities.
- Medical
Where is Spain’s Long Awaited Medical Cannabis Market?
Spain’s long-awaited and hard-fought legislation to launch a medical cannabis market in the country has been slammed by pharmacists, patient advocacy groups and cannabis businesses.
- Adult-Use
Florida & North Dakota Vote Against Cannabis Legalization, But Nebraska Approves Medical Cannabis Bills
Beyond the presidential result, yesterday key cannabis reform votes took place across numerous states, poised to have a significant impact the US cannabis industry.
- Opinion
Incumbent UK Providers Are the ‘Root Cause of the Sector’s Stagnation Since the Legalisation of Medical Cannabis in 2018′
Since the UK legalisation of CBPMs in 2018, the sector has faced slow adoption due to ineffective patient outreach, inconsistent supply chains and variable quality control from other providers.
